ZLD zelira therapeutics limited
Add to My Watchlist 0.00% ! 50.0¢

Ann: US Autism Observational Study Receives IRB Approval

  1. ASX News
    lightbulb Created with Sketch.  851
    clock Created with Sketch.
    13/04/18
    10:07
    Post #: 32429074
    • Release Date: 13/04/18 09:47
    • Summary: US Autism Observational Study Receives IRB Approval
    • Price Sensitive: No
    • Download Document    Not available as of the moment.
    Likes Created with Sketch. 8  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Resmed turns in record fourth quarter revenue of US$1.5B
right-arrow Created with Sketch.
NEWS AVITA Medical raises 2026 outlook after record second quarter
right-arrow Created with Sketch.
NEWS Want to reach millions of investors? Get in touch
right-arrow Created with Sketch.
NEWS Tivan agrees to project finance mandate for Speewah fluorite project
right-arrow Created with Sketch.
NEWS HotCopper Highlights, Week 32: Rare earths, lithium, and gas dominate conversations
right-arrow Created with Sketch.
NEWS Read the Latest ASX News here on HotCopper
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
50.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $5.948M
Open High Low Volume
0.0¢ 0.0¢ 0.0¢ 0
Last trade - 10.00am 13/08/2026 (20 minute delay) ?
ZLD (ASX) Chart
Day chart unavailable
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.